Recent Annual Reports

Browse the latest SEC filings with AI-powered analysis. Get insights into corporate performance, financial trends, and business developments.

📊 5202 Reports

🤖 AI Analyzed

Recent

📄 Page 58 of 434

Ensysce Biosciences, Inc.

10-K March 30, 2026

Key Highlights

Proprietary TAAP and MPAR platforms designed to create safer, abuse-deterrent pa...
Advancing lead clinical-stage candidates PF614 and PF614-MPAR through Phase 3 tr...
Focused on addressing the critical market need for non-opioid or safer pain mana...

Read Analysis

🤖 AI Generated

PSNH FUNDING LLC 3

10-K March 30, 2026

Key Highlights

Predictable, state-regulated cash flows from mandatory customer fees
Bankruptcy-remote structure protects assets from parent company risks
Consistent debt repayment schedule with full principal and interest paid in 2025

Read Analysis

🤖 AI Generated

MeiraGTx Holdings plc

10-K March 30, 2026

Key Highlights

Vertically integrated manufacturing capabilities with commercial-grade authoriza...
Proprietary 'riboswitch' technology acts as a biological dimmer switch for preci...
Strategic partnership with Johnson & Johnson provides non-dilutive capital and m...

Read Analysis

🤖 AI Generated

REVIVA PHARMACEUTICALS HOLDINGS, INC.

10-K March 30, 2026

Key Highlights

Advancing Brilaroxazine as a potential treatment for schizophrenia
Successfully raised $15 million in capital to sustain clinical operations
Focused on reaching critical RECOVER-2 trial results in 2026

Read Analysis

🤖 AI Generated

Fathom Holdings Inc.

10-K March 30, 2026

Key Highlights

Cloud-based brokerage model offers agents 25% higher earnings than traditional f...
New 2024 revenue streams include Fathom Max flat-fee and Fathom Share recruitmen...
Strategic focus on increasing 'attach rates' for mortgage, title, and insurance ...

Read Analysis

🤖 AI Generated

Lantern Pharma Inc.

10-K March 30, 2026

Key Highlights

FDA clearance for two Phase 1b/2 clinical trials for lead drug LP-184.
Launch of withZeta.ai, a generative AI co-scientist that accelerates biomarker d...
Expansion of RADR® platform with 160+ new machine learning algorithms, including...

Read Analysis

🤖 AI Generated

Unicycive Therapeutics, Inc.

10-K March 30, 2026

Key Highlights

Lead drug OLC has a critical FDA target decision date of June 29, 2026.
Resubmission of OLC application follows successful resolution of manufacturing q...
Development of UNI-494 offers potential for treating Acute Kidney Injury, a mark...

Read Analysis

🤖 AI Generated

American Picture House Corp

10-K March 30, 2026

Key Highlights

Strategic shift from consulting to film financing and production
Priority repayment rights on film loans ensure first-position claims
Growing library of five completed films generating recurring revenue

Read Analysis

🤖 AI Generated

AEP Texas Restoration Funding LLC

10-K March 30, 2026

Key Highlights

Stable, predictable cash flows backed by mandated utility charges.
Special-purpose structure designed specifically for bond repayment.
Regulatory 'true-up' mechanism ensures revenue aligns with debt obligations.

Read Analysis

🤖 AI Generated

CISO Global, Inc.

10-K March 30, 2026

Key Highlights

Strong recurring revenue model with 70% to 80% of income coming from monthly sub...
Significant cross-selling potential with only 20% of the 437-client base current...
Strategic shift to a product-led model using internal automation to improve prof...

Read Analysis

🤖 AI Generated

Lulu's Fashion Lounge Holdings, Inc.

10-K March 30, 2026

Key Highlights

Wholesale revenue surged 144% to $25 million, signaling strong growth in retail ...
Agile 'test, learn, and reorder' inventory model minimizes unsold stock.
New CFO Heidi Crane appointed to lead financial stabilization efforts.

Read Analysis

🤖 AI Generated

BioScience Health Innovations, Inc.

10-K March 30, 2026

Key Highlights

Achieved significant revenue growth of 208% year-over-year to $5.69 million.
Transitioned to profitability with $642,090 in net income for 2025.
Improved profit margins from 4.7% to 11.3% through operational efficiencies.

Read Analysis

🤖 AI Generated

Stay Informed with AI Analysis

Get comprehensive insights from annual reports with our AI-powered analysis. Track corporate performance, financial trends, and strategic developments.

Back to Homepage